Opposite effects of the gap junction blocker octanol on focal cerebral ischemia occluded for different durations

Ding,Wenting; Zhou,Lequan; Liu,Wei; Guan,Li; Li,Xiaoying; Liu,Haimei; Yan,Fuman; Xu,Jinwen; Zeng,Weiyong; Qiu,Min

doi:10.3892/mmr.2014.2075

Opposite effects of the gap junction blocker octanol on focal cerebral ischemia occluded for different durations

Authors:
- Wenting Ding
- Lequan Zhou
- Wei Liu
- Li Guan
- Xiaoying Li
- Haimei Liu
- Fuman Yan
- Jinwen Xu
- Weiyong Zeng
- Min Qiu
View Affiliations

Affiliations: Department of Physiology, College of Fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China, Department of Physiology, College of Fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China
Published online on: March 27, 2014 https://doi.org/10.3892/mmr.2014.2075
Pages: 2485-2490

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Protectants and executioners have been demonstrated to be used by gap junctions in focal cerebral ischemia. Certain researchers hypothesized that the opposite role of gap junctions may be associated with the injury extent, which has been demonstrated to be highly correlated with occlusion duration. In order to examine this hypothesis directly, the effects of octanol, a frequently used drug, were examined to investigate the role of gap junctions, in rats following middle cerebral artery occlusion (MCAO) for 30 min/2 h and 24 h reperfusion, respectively. Octanol significantly reduced the infarct volume following 2 h of occlusion concomitant with lower neurological deficits, whereas it enlarged the infarct volume following 30 min of occlusion. Consistently, octanol attenuated the number of transferase dUTP nick-end labeling (TUNEL) positive neurons in the hippocampal CA1 region following 2 h of occlusion, while opposite effects were observed for 30 min of occlusion. Further immunohistochemical studies demonstrated that the expression of B-cell leukemia-2 (Bcl-2, anti-apoptotic protein) was upregulated and that Bcl-2-associated X (Bax, proapoptotic protein) was downregulated following 2 h of occlusion in the octanol group compared with the ischemic group. Conversely, octanol downregulated the expression of the Bcl-2 protein concomitant with increased Bax protein following 30 min of occlusion. These results indicated that the gap junction blocker octanol can protect against ischemic injury following long-term occlusion, however, can aggravate ischemic injury following short-term occlusion.

View Figures

View References

1	Krysko DV, Leybaert L, Vandenabeele P and D’Herde K: Gap junctions and the propagation of cell survival and cell death signals. Apoptosis. 10:459–469. 2005. View Article : Google Scholar : PubMed/NCBI
2	Peixoto PM, Ryu SY, Pruzansky DP, Kuriakose M, Gilmore A and Kinnally KW: Mitochondrial apoptosis is amplified through gap junctions. Biochem Biophys Res Commun. 390:38–43. 2009. View Article : Google Scholar : PubMed/NCBI
3	Sahores M and Mendoza-Naranjo A: Gap junctions as therapeutic targets in brain injury following hypoxia-ischemia. Recent Pat CNS Drug Discov. 3:209–315. 2008. View Article : Google Scholar : PubMed/NCBI
4	Spray DC, Hanstein R, Lopez-Quintero SV, Stout RF Jr, Suadicani SO and Thi MM: Gap junctions and Bystander effects: Good Samaritans and executioners. Wiley Interdiscip Rev Membr Transp Signal. 2:1–15. 2013. View Article : Google Scholar : PubMed/NCBI
5	Davidson JO, Green CR, Bennel L, Nicholson LF, Danesh-Meyer H, O’Carroll SJ and Gunn AJ: A key role for connexin hemichannels in spreading ischemic brain injury. Curr Drug Targets. 14:36–46. 2013. View Article : Google Scholar : PubMed/NCBI
6	Rami A, Volkmann T and Winckler J: Effective reduction of neuronal death by inhibiting gap junctional intercellular communication in a rodent model of global transient cerebral ischemia. Exp Neurol. 170:297–304. 2001. View Article : Google Scholar
7	Xie M, Yi C, Luo X, et al: Glial gap junctionsal communication involvement in hippocampal damage after middle cerebral artery occlusion. Ann Neurol. 70:121–132. 2011. View Article : Google Scholar : PubMed/NCBI
8	Lin JH, Weigel H, Cotrina ML, et al: Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci. 1:494–500. 1998. View Article : Google Scholar : PubMed/NCBI
9	Blanc EM, Bruce-Keller AJ and Mattson MP: Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca²⁺ homeostasis and cell death. J Neurochem. 70:958–970. 1998. View Article : Google Scholar : PubMed/NCBI
10	Ozog MA, Siushansian R and Naus CC: Blocking gap junctional coupling increases glutamate-induced neurotoxicity in neuron-astrocyte co-cultures. J Neuropathol Exp Neurol. 61:132–141. 2002.PubMed/NCBI
11	Lee J, Yim YS, Ko SJ, Kim DG and Kim CH: Gap junctions contribute to astrocytic resistance against zinc toxicity. Brain Res Bull. 86:314–318. 2011. View Article : Google Scholar : PubMed/NCBI
12	Chew SS, Johnson CS, Green CR and Danesh-Meyer HV: Role of connexin43 in central nervous system injury. Exp Neurol. 225:250–261. 2010. View Article : Google Scholar : PubMed/NCBI
13	Bendel O, Alkass K, Bueters T, von Euler M and von Euler G: Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Res. 1033:135–142. 2005. View Article : Google Scholar : PubMed/NCBI
14	Colbourne F, Li H and Buchan AM: Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke. 30:662–668. 1999. View Article : Google Scholar : PubMed/NCBI
15	Rawanduzy A, Hansen A, Hansen TW and Nedergaard M: Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg. 87:916–920. 1997.
16	Kaido T, Kempski O, Heimann A, Heers C and Bartsch D: Cluster analysis of mRNA expression levels identifies multiple sequential patterns following focal cerebral ischemia. Turk Neurosurg. 22:441–447. 2012.
17	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
18	Zivin JA: Factors determining the therapeutic window for stroke. Neurology. 50:599–603. 1998. View Article : Google Scholar : PubMed/NCBI
19	George A, Marziniak M, Schäfers M, Toyka KV and Sommer C: Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain. 88:267–275. 2000. View Article : Google Scholar
20	Narahashi T, Aistrup GL, Lindstrom JM, Marszalec W, Nagata K, Wang F and Yeh JZ: Ion channel modulation as the basis for general anesthesia. Toxicol Lett. 100:185–191. 1998. View Article : Google Scholar
21	Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MV and Sáez JC: Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev. 47:290–303. 2004. View Article : Google Scholar : PubMed/NCBI
22	Retamal MA, Schalper KA, Shoji KF, Orellana JA, Bennett MV and Sáez JC: Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion. J Membr Biol. 218:49–63. 2007. View Article : Google Scholar
23	Rouach N, Avignone E, Même W, Koulakoff A, Venance L, Blomstrand F and Giaume C: Gap junctions and connexin expression in the normal and pathological central nervous system. Biol Cell. 94:457–475. 2002. View Article : Google Scholar : PubMed/NCBI
24	Talhouk RS, Zeinieh MP, Mikati MA and El-Sabban ME: Gap junctional intercellular communication in hypoxia-ischemia-induced neuronal injury. Prog Neurobiol. 84:57–76. 2008. View Article : Google Scholar : PubMed/NCBI
25	Lin JH, Lou N, Kang N, et al: A central role of connexin 43 in hypoxic preconditioning. J Neurosci. 28:681–695. 2008. View Article : Google Scholar : PubMed/NCBI
26	Nakase T, Fushiki S and Naus CC: Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia. Stroke. 34:1987–1993. 2003. View Article : Google Scholar : PubMed/NCBI
27	Nakase T, Fushiki S, Söhl G, Theis M, Willecke K and Naus CC: Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Commun Adhes. 10:413–417. 2003. View Article : Google Scholar : PubMed/NCBI
28	Nakase T, Sähl G, Theis M, Willecke K and Naus CC: Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol. 164:2067–2075. 2004. View Article : Google Scholar : PubMed/NCBI
29	Siushansian R, Bechberger JF, Cechetto DF, Hachinski VC and Naus CC: Connexin43 null mutation increases infarct size after stroke. J Comp Neurol. 440:387–394. 2001. View Article : Google Scholar : PubMed/NCBI
30	Wang F, Hai J and Jing Y: Gap junctions communication involved in brain protection following focal ischemia and reperfusion in rats. Neural Regen Res. 9:677–682. 2009.(In Chinese).
31	Perez Velazquez JL, Kokarovtseva L, Sarbaziha R, Jeyapalan Z and Leshchenko Y: Role of gap junctionsal coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage. Eur J Neurosci. 23:1–10. 2006.PubMed/NCBI
32	Saito R, Graf R, Hübel K, Fujita T, Rosner G and Heiss WD: Reduction of infarct volume by halothane: effect on cerebral blood flow or perifocal spreading depression-like depolarizations. J Cereb Blood Flow Metab. 17:857–864. 1997.PubMed/NCBI
33	de Pina-Benabou MH, Szostak V, Kyrozis A, et al: Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia. Stroke. 36:2232–2237. 2005.PubMed/NCBI
34	Martinou JC, Dubois-Dauphin M, Staple JK, et al: Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1017–1030. 1994. View Article : Google Scholar : PubMed/NCBI
35	Chen J, Simon RP, Nagayama T, Zhu R, Loeffert JE, Watkins SC and Graham SH: Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J Cereb Blood Flow Metab. 20:1033–1039. 2000. View Article : Google Scholar : PubMed/NCBI
36	MacManus JP and Linnik MD: Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cereb Blood Flow Metab. 17:815–832. 1997. View Article : Google Scholar : PubMed/NCBI
37	Han B, Wang Q, Cui G, Shen X and Zhu Z: Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia. Neurochem Int. 58:224–233. 2011. View Article : Google Scholar : PubMed/NCBI
38	Xi HJ, Zhang TH, Tao T, Song CY, Lu SJ, Cui XG and Yue ZY: Propofol improved neurobehavioral outcome of cerebral ischemia-reperfusion rats by regulating Bcl-2 and Bax expression. Brain Res. 1410:24–32. 2011. View Article : Google Scholar : PubMed/NCBI